flammable
发表于 2025-3-30 09:34:22
Matthieu Lauras,Jorge Vargas,Lionel Dupont,Aurelie Charlesipsychotics though do not conform to that therapeutic window, notably clozapine. The reasons for its unexcelled clinical efficacy despite subthreshold levels of D. blockade are unclear and current theories on clozapine’s mechanisms of action are discussed, including transiency of its D. receptor blo
担心
发表于 2025-3-30 15:27:06
http://reply.papertrans.cn/47/4656/465584/465584_52.png
易受刺激
发表于 2025-3-30 16:51:31
Van-Minh Le,Yann Chevaleyre,Jean-Daniel Zucker,Ho Tuong Vinhipsychotics though do not conform to that therapeutic window, notably clozapine. The reasons for its unexcelled clinical efficacy despite subthreshold levels of D. blockade are unclear and current theories on clozapine’s mechanisms of action are discussed, including transiency of its D. receptor blo
ANTE
发表于 2025-3-31 00:44:01
Stefania Traverso,Valentina Cerutti,Kristin Stock,Mike Jacksonlutamate in schizophrenia, SPECT as well as MR spectroscopy have been used. The results of preliminary SPECT studies are consistent with the hypothesis of NMDA receptor dysfunction in schizophrenia. Regarding the GABA deficit hypothesis of schizophrenia, imaging results are inconsistent. No changes
infatuation
发表于 2025-3-31 03:58:31
Ahmed Maalel,Lassad Mejri,Habib Hadj-Mabrouk,Henda Ben Ghézalalutamate in schizophrenia, SPECT as well as MR spectroscopy have been used. The results of preliminary SPECT studies are consistent with the hypothesis of NMDA receptor dysfunction in schizophrenia. Regarding the GABA deficit hypothesis of schizophrenia, imaging results are inconsistent. No changes
projectile
发表于 2025-3-31 08:37:06
http://reply.papertrans.cn/47/4656/465584/465584_56.png
vibrant
发表于 2025-3-31 11:44:08
http://reply.papertrans.cn/47/4656/465584/465584_57.png
Capitulate
发表于 2025-3-31 15:36:26
http://reply.papertrans.cn/47/4656/465584/465584_58.png
Bridle
发表于 2025-3-31 19:59:06
Mohammed Ouzzif,Marouane Hamdani,Hassan Mountassir,Mohammed Erradiccult distant metastases. The whole subject of adjuvant therapy is still in its infancy. We have progressed from single-agent adjuvant chemotherapy to combined modality regimens consisting of combination chemotherapy plus im munotherapy, plus radiotherapy, plus endocrine therapy. It will un doubte